During the past decade, Aichi Cancer Center conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 3 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Aichi Cancer Center" #1 sponsor was "Amgen" with 9 trials, followed by "Hoffmann-La Roche" with 7 trials sponsored, "Seagen Inc." with 3 trials sponsored, "Puma Biotechnology, Inc." with 2 trials sponsored and "Orient Europharma Co., Ltd." with 2 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Aichi Cancer Center" #1 collaborator was "Foundation Medicine, Inc." with 1 trials as a collaborator and "NanoCarrier Co., Ltd." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 2 trials.

According to Clinical.Site data, the most researched conditions in "Aichi Cancer Center" are "Advanced Solid Tumors" (2 trials), "Breast Cancer" (2 trials), "Carcinoma, Non-Small-Cell Lung" (2 trials), "Advanced Breast Cancer" (1 trials) and "Advanced MTAP-null Solid Tumors" (1 trials). Many other conditions were trialed in "Aichi Cancer Center" in a lesser frequency.

Most popular intervention types in "Aichi Cancer Center" are "Drug" (24 trials), "Combination Product" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Atezolizumab" (4 trials), "Gemcitabine" (3 trials), "tucatinib" (3 trials), "Bemarituzumab" (2 trials) and "Carboplatin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Aichi Cancer Center" are 22 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Aichi Cancer Center". undefined are not yet recruiting, 11 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Aichi Cancer Center, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Aichi Cancer Center, 8 "Phase 1" clinical trials were conducted, 9 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".